Loading clinical trials...
Loading clinical trials...
This epidemiological, transversal, cohort study aims to determine the potential influence of an active long-term hydroxychloroquine intake over the prevalence of a history of symptoms evocative of a COVID-19 infection in patients with a history of systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome or psoriatic arthritis, during the epidemic period in France. The information is gathered using a standardized questionnaire, by phone call.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Fondation Adolphe de Rothschild
Paris, France
Start Date
April 17, 2020
Primary Completion Date
November 30, 2020
Completion Date
November 30, 2020
Last Updated
January 7, 2021
572
ACTUAL participants
Questionnaire by phone call
OTHER
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
NCT06647069
NCT07484243
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions